Skip to main content
Clinical Trials/NCT00502372
NCT00502372TerminatedPhase 1

Nutritional Effect of an Oral Supplement Enriched in Arginine, Glutamine and Leucine Metabolite B-Hydroxy B-Methylbutyrate

Central Arkansas Veterans Healthcare System1 site in 1 country9 target enrollmentStarted: December 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Terminated
Enrollment
9
Locations
1
Primary Endpoint
PUSH tool score

Study Overview

Brief Summary

The focus of this study is to look at the role of nutrition in the healing of pressure ulcers. The purpose of this study is to test whether the rate of healing of pressure ulcers is increased in those patients receiving a nutritional supplement of amino acids and the leucine metabolite, B-hydroxy-B-methylbutyrate is enhanced when compared to control patients receiving a supplement containing only one of the proteins in the experimental supplement

Detailed Description

Patients who have pressure ulcers Stage II or greater will be randomized to receiving one of two nutritional supplements. One supplement contains arginine and the other contains both arginine,glutamine and leucine metabolites. Pressure ulcers will be measured at study entry and measured biweekly using a standardized tool (PUSH) until the trial is completed or the pressure ulcer has healed.

Inclusion criteria include:

  • Stage II or greater pressure ulcer
  • Patient consent
  • Patients who can drink supplement or receive it by tube
  • Patients who are 21 years old or greater

Exclusion criteria include:

  • Patients with infected wounds
  • Patients with cellulitis, sepsis or osteomyelitis
  • Patients with end-organ failure
  • Patients with poorly controlled diabetes mellitus (HbA1C>10)
  • Patients who cannot tolerate oral or tube feeding

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
21 Years to 90 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with Stage II pressure ulcer or greater
  • •Patients who consent to participate
  • •Patients who can ingest the supplement either orally or per feeding tube
  • •Patients who are 21 years of age or older

Exclusion Criteria

  • •Patients with infected wounds
  • •Patients with cellulitis, sepsis or osteomyelitis
  • •Patients with end-organ failure
  • •Patients with poorly controlled diabetes mellitus (HbA1C>10)
  • •Patients who cannot tolerate oral or bolus tube feedings

Arms & Interventions

Enriched product, dietary supplement

Experimental

Subjects receiving enriched product compared to an unenriched product

Intervention: Nutritional Supplement/Amino acids and HMB (Dietary Supplement)

Enriched product, dietary supplement

Experimental

Subjects receiving enriched product compared to an unenriched product

Intervention: Juven (Dietary Supplement)

1

Active Comparator

Subjects not receiving enriched product

Intervention: Nutritional Supplement/Amino acids and HMB (Dietary Supplement)

1

Active Comparator

Subjects not receiving enriched product

Intervention: Juven (Dietary Supplement)

Outcomes

Primary Outcomes

PUSH tool score

Time Frame: 8 weeks or healing completed

The PUSH tool measures the healing of a pressure ulcer by actually measuring the depth and width, in 2 dimensions, of a wound. A wound heals from the wound bed and closes from the inside to the outside if healthy pink granulation tissue can be seen. This tool contributes to the consistency of measurement of a healing wound.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Fed
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials